Company Description
Oaktree Acquisition III (NASDAQ: OACCW) is classified in the Blank Checks sector.
OACCW has gained 26.6% over the past year. Shares last traded at $1.03.
For FY2025, Oaktree Acquisition III reported net income of $7.3M.
This page collects what Stock Titan holds for OACCW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Oaktree Acquisition III (OACCW) stock last closed at $1.03. Over the past 12 months, the stock has gained 26.6%.
Latest News
Oaktree Acquisition III has 1 recent news article. Key topics include acquisition. View all OACCW news →
SEC Filings
Oaktree Acquisition III has filed 5 recent SEC filings, including 3 Form SCHEDULE 13G, 2 Form 10-Q. The most recent filing was submitted on August 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OACCW SEC filings →
Financial Highlights
operating income reached -$1.2M, and net income was $7.3M. The company generated -$422K in operating cash flow. With a current ratio of 1.19, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in Oaktree Acquisition III (OACCW) currently stands at 516 shares, down 81.3% from the previous reporting period. Since August 2025, short interest has decreased by 32.5%.
Days to Cover History
Days to cover for Oaktree Acquisition III (OACCW) currently stands at 1.2 days, up 16% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 572.0 days.
OACCW Company Profile & Sector Positioning
Oaktree Acquisition III (OACCW) operates in the Blank Checks sector and is listed on the NASDAQ.
Investors comparing OACCW often look at related companies in the same sector, including Hennessy Cap (HVIIU), Voyager Acqsn (VACHU), Medtech Acquisition Corp (MTACU), Oaktree Acquisition Corp. III Life Sciences (OACCU), and Winvest Acquisition Corp (WINVU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OACCW's relative position within its industry.